Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Imperial Optical, Inc. Partners with DaVinci Laboratories
contact lens distributor and natural supplement and nutraceuticals provider partner to offer to provide online access to an exclusive line of eye health supplements to Imperial Optical’s ECP WebSolutions subscribers.
- Imperial Optical, Inc. Partners with DaVinci Laboratories
contact lens distributor and natural supplement and nutraceuticals provider partner to offer to provide online access to an exclusive line of eye health supplements to Imperial Optical’s ECP WebSolutions subscribers.
- Imperial Optical, Inc. Partners with DaVinci Laboratories
contact lens distributor and natural supplement and nutraceuticals provider partner to offer to provide online access to an exclusive line of eye health supplements to Imperial Optical’s ECP WebSolutions subscribers.
- Imperial Optical, Inc. Partners with DaVinci Laboratories
contact lens distributor and natural supplement and nutraceuticals provider partner to offer to provide online access to an exclusive line of eye health supplements to Imperial Optical’s ECP WebSolutions subscribers.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Study Shows Supplementing With Martek DHA(TM) While Breastfeeding Improves Psychomotor Skills in Toddlers
Double-blind, placebo-controlled study published this month in the American Journal of Clinical Nutrition indicates that children of DHA-supplemented moms scored significantly higher on the Bayley Psychomotor Development Index (PDI), when compared to the children of the non-supplemented breastfeeding moms.
- Study Shows Supplementing With Martek DHA(TM) While Breastfeeding Improves Psychomotor Skills in Toddlers
Double-blind, placebo-controlled study published this month in the American Journal of Clinical Nutrition indicates that children of DHA-supplemented moms scored significantly higher on the Bayley Psychomotor Development Index (PDI), when compared to the children of the non-supplemented breastfeeding moms.
- Study Shows Supplementing With Martek DHA(TM) While Breastfeeding Improves Psychomotor Skills in Toddlers
Double-blind, placebo-controlled study published this month in the American Journal of Clinical Nutrition indicates that children of DHA-supplemented moms scored significantly higher on the Bayley Psychomotor Development Index (PDI), when compared to the children of the non-supplemented breastfeeding moms.
- Study Shows Supplementing With Martek DHA(TM) While Breastfeeding Improves Psychomotor Skills in Toddlers
Double-blind, placebo-controlled study published this month in the American Journal of Clinical Nutrition indicates that children of DHA-supplemented moms scored significantly higher on the Bayley Psychomotor Development Index (PDI), when compared to the children of the non-supplemented breastfeeding moms.
- Study: Pycnogenol(R) Can Help Prevent Leg, Ankle Swelling on Long Airline Flights
double-blind, placebo controlled study published in the July 2005 issue of Clinical and Applied Thrombosis/Hemostasis tested in-flight ankle swelling for 169 participants and found that untreated passengers showed increased ankle swelling almost twice as high as in the group of passengers supplemented with Pycnogenol®.
- Study: Pycnogenol(R) Can Help Prevent Leg, Ankle Swelling on Long Airline Flights
double-blind, placebo controlled study published in the July 2005 issue of Clinical and Applied Thrombosis/Hemostasis tested in-flight ankle swelling for 169 participants and found that untreated passengers showed increased ankle swelling almost twice as high as in the group of passengers supplemented with Pycnogenol®.
- Study: Pycnogenol(R) Can Help Prevent Leg, Ankle Swelling on Long Airline Flights
double-blind, placebo controlled study published in the July 2005 issue of Clinical and Applied Thrombosis/Hemostasis tested in-flight ankle swelling for 169 participants and found that untreated passengers showed increased ankle swelling almost twice as high as in the group of passengers supplemented with Pycnogenol®.
- Study: Pycnogenol(R) Can Help Prevent Leg, Ankle Swelling on Long Airline Flights
double-blind, placebo controlled study published in the July 2005 issue of Clinical and Applied Thrombosis/Hemostasis tested in-flight ankle swelling for 169 participants and found that untreated passengers showed increased ankle swelling almost twice as high as in the group of passengers supplemented with Pycnogenol®.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
SAN DIEGO, Jun 13, 2005 (BUSINESS WIRE) -- Today, Nutrition 21, Inc. (NXXI) reported results from a new clinical trial that show daily supplementation with Diachrome(R), a nutritional combination of chromium picolinate and biotin, can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting. The results of the randomized, double-blind, placebo-controlled, multi-center study that evaluated 369 subjects were presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. A recent survey found that an estimated 67% of people with diabetes have poorly-controlled blood sugar levels, greatly increasing their risk of cardiovascular disease, blindness, and nerve and kidney damage over time. The Diachrome study results included an analysis of an ethnically diverse population of people with diabetes receiving intensive and highly personalized care, who were already on a variety of prescription antidiabetic medications, yet still did not have their blood sugar levels at the recommended goal of (less than) 7% HbA1c. While there was a significant reduction in HbA1c overall in study participants taking Diachrome, the most dramatic improvements were seen in subjects with the most poorly controlled HbA1c levels at baseline (greater than (10%)). After 90 days, the blood sugar levels of these patients dropped significantly (greater than (1.9%-point drop in HbA1c)). Additionally, Diachrome significantly lowered LDL cholesterol (-21.9 mg/dL,) in subjects with poorly controlled cholesterol levels (greater than (200 mg/dL)) at baseline.
"These findings are significant. The average reduction in blood sugar levels is comparable to the effect typically seen when adding a second prescription therapy. There was no observed risk of hypoglycemia," said lead researcher Cesar Albarracin, M.D., Medical Director of Alpha Therapy in Corpus Christi, TX. "Diachrome's dual benefit for safely improving both blood glucose and cholesterol levels in the most severe diabetics is significant, as these subjects are generally the hardest to control, the most costly to care for and the most likely to develop significant complications."
Nutrition 21, Inc. conducted the landmark study in collaboration with XLHealth, a nationally recognized disease management firm handling chronically ill patients for the Centers for Medicare and Medicaid Services (CMS). "The presentation of this data is an important business milestone that will help facilitate the use of Diachrome in clinical practice," said Gail Montgomery, president and CEO, Nutrition 21. "Diachrome could be a safe, cost-effective means of helping the vast majority of people with diabetes that have poorly controlled blood sugar levels."
Certain ethnic minorities, including Hispanics have a higher prevalence of diabetes than Caucasians, and some minorities have higher rates of diabetes-related complications and death, according to the Agency for Healthcare Research and Quality. "More than 30 percent of the study participants were Hispanic, making this trial the first to examine the effects of Diachrome supplementation in this high risk population," said Dr. Albarracin.
Diachrome is a nutritional supplement specifically formulated for people with diabetes. It contains 600 mcg of chromium as Chromax(R) chromium picolinate and 2 mg of biotin. These two compounds are both Generally Recognized as Safe (GRAS) for use as ingredients in food and supplements. It is available for purchase by calling 1-866-DIACHROME or at www.diachrome.com.
About Nutrition 21
Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The company markets Chromax chromium picolinate, which is the most-studied form of the essential mineral chromium. Nutrition 21 also developed Diachrome, which is available through diabetes educators or at www.diachrome.com. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at www.nutrition21.com. |